# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sugar Ray Robinson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX003-SYN-TD
- Date: 1984-07-07
- Fictional facility: St. Posthumous Health Center
- Fictional author: Langston Pryce-Okonjo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Establishing care for memory loss and getting lost, with his care partner: cognitive testing, reversible causes, medicines, diabetes and blood pressure, driving and firearm safety. **S**

## Historical basis

- He was born Walker Smith Jr. on May 3, 1921. The Michigan Sports Hall of Fame gives his birthplace as Ailey, Georgia, with the family later moving to Detroit; the 1989 UPI obituary says he was born in Detroit. **D**
- As a boy he moved with his family to Harlem in New York, and he won the Golden Gloves featherweight title in 1939. **D**
- He held the world welterweight championship, won in 1946, and the world middleweight title five times, first in 1951. **D**
- He boxed professionally from 1940 to 1965, about 200 bouts in all: the 1989 UPI obituary counts 201 fights, 109 won by knockout and 65 by decision; the 1987 UPI report gives a record of 174-19-6 and the Michigan Sports Hall of Fame 173-19-6. **D**
- After boxing he settled in Los Angeles, living modestly in the top story of a duplex on West Adams Boulevard, and in 1969 founded the Sugar Ray Robinson Youth Foundation for inner-city children in the Los Angeles area. **D**
- The project roster describes his dementia as probable boxing-related dementia pugilistica; no source read records that diagnosis, chronic traumatic encephalopathy, or an autopsy finding. **R**

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He wants to know why he is forgetting and what can be done. **S**
- He wants to keep his independence and keep working with the young fighters at the foundation. **S**
- His care partner is worried about his driving and about managing alone. **S**

## Strengths and supports

- Strengths and supports: discipline and daily exercise, pride in his career, a warm and sociable manner, his care partner, friends from boxing, and the young people at the foundation **S**

## Medications and allergies

- Metformin 1,000 mg oral tablet, one tablet twice daily with meals **S**
- Glipizide 5 mg oral tablet, one tablet before breakfast **S**
- Lisinopril 20 mg oral tablet, one tablet daily **S**
- Atorvastatin 20 mg oral tablet, one tablet daily **S**
- Diphenhydramine 25 mg oral capsule, one at bedtime for sleep, bought over the counter **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1940 to 1965: About 200 professional bouts over 25 years of boxing, after an amateur career: long exposure to repetitive head impacts; no source read records a knockout count with loss of consciousness or a brain injury diagnosis **D** (CLM-0002, CLM-0004)

## Procedures and immunizations

- No procedures before this visit. **S**


## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

White blood cells: 6.4 10*3/uL; Hemoglobin: 14.1 g/dL; Platelets: 231 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 1 mg/dL; eGFR (CKD-EPI 1979): 85 mL/min/1.73 m²; Glucose: 126 mg/dL; Hemoglobin A1c: 6.4% (high); Vitamin B12: 352 pg/mL; TSH: 1.9 mIU/L; Urine albumin-to-creatinine ratio: 14 mg/g; MoCA: 18; PHQ-9: 4. All results are synthetic.

BP 132/80 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 77 kg; BMI 23.8 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, cheerful and courteous; repeats a question twice in ten minutes; looks to his care partner for dates; speech fluent; mood good; no hallucinations or delusions; insight partial: he notices forgetting but feels it is normal for his age. Functional status: Independent in bathing, dressing, eating and walking; needs help with bills, medicines and appointments (Functional Activities Questionnaire 11, narrative); Timed Up and Go 9 seconds. Physical examination is intentionally limited. **S**

## Assessment

1. Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be found; status draft. **S**
2. Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylurea; status draft. **S**
3. Hypertension, controlled on lisinopril; status draft. **S**

## Plan

- Dementia work-up under the Alzheimer's Association guideline: history from him and his care partner, MoCA, function, depression screening, first-tier blood tests (blood count, metabolic panel, B12, TSH), a review of medicines for anticholinergic and sedating drugs, a sleep apnea screen, and brain MRI. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2024); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, diabetes type 2 and hypertension monographs (2026) **S**
- Cognitive neurology consultation at the memory clinic to stage the dementia, weigh Alzheimer's disease against traumatic encephalopathy syndrome and vascular disease, choose biomarker testing, and decide anti-amyloid eligibility. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); Lecanemab: Appropriate Use Recommendations (2023); Donanemab: Appropriate use recommendations (2025); National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021) **S**
- Stop diphenhydramine, a strongly anticholinergic sleep aid; sleep habits and morning light instead. Guideline: American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023) **S**
- Driving: no driving until the evaluation is complete, with his care partner driving; firearm: unloaded and locked, with the key held by his care partner, until a decision with him. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); Practice Parameter update: Evaluation and management of driving risk in dementia (2010) **S**
- Blood pressure under 130/80 mmHg on lisinopril, with potassium and creatinine checks. Guideline: CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, diabetes type 2 and hypertension monographs (2026); 13. Older Adults: Standards of Care in Diabetes-2026 (2026) **S**
- Advance care planning while he can take part fully: a health care agent and his values, at the preventive visit. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024) **S**
- Exercise, social activity and diabetes and blood pressure control as the brain-health measures with the most support. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); 13. Older Adults: Standards of Care in Diabetes-2026 (2026) **S**

## Guideline basis

- Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024), Alzheimer's Association (Alzheimers Dement 2025;21(1):e14337)
- Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2024), Alzheimer's Association (Alzheimers Dement 2025)
- CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, diabetes type 2 and hypertension monographs (2026), Aether Forge
- Lecanemab: Appropriate Use Recommendations (2023), J Prev Alzheimers Dis 2023;10(3):362-377 (Cummings J et al.)
- Donanemab: Appropriate use recommendations (2025), J Prev Alzheimers Dis 2025;12(5):100150 (Rabinovici GD et al.)
- National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021), Neurology 2021;96(18):848-863
- 13. Older Adults: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1):S277-S296)
- American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023), American Geriatrics Society (Journal of the American Geriatrics Society)
- Practice Parameter update: Evaluation and management of driving risk in dementia (2010), American Academy of Neurology (Neurology 2010;74(16):1316-1324)
